These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10359368)

  • 1. Pediatricians alerted to five new vaccines.
    Jefferson T
    JAMA; 1999 Jun; 281(21):1973-5. PubMed ID: 10359368
    [No Abstract]   [Full Text] [Related]  

  • 2. Borrelia burgdorferi and other bacterial products induce expression and release of the urokinase receptor (CD87).
    Coleman JL; Gebbia JA; Benach JL
    J Immunol; 2001 Jan; 166(1):473-80. PubMed ID: 11123326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lyme disease vaccine.
    Schofield DH; Parenti D
    JAMA; 2000 Jan; 283(2):199; author reply 200. PubMed ID: 10634331
    [No Abstract]   [Full Text] [Related]  

  • 4. Borrelia burgdorferi outer surface protein A vaccine: importance, role, and value.
    Sigal LH
    J Pediatr; 1999 Nov; 135(5):539-41. PubMed ID: 10547238
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody responses of rats and humans to flagella-less cells and OspA protein of Borrelia burgdorferi.
    Sadziene A; Thompson PA; Barbour AG
    Ann N Y Acad Sci; 1996 Oct; 797():140-50. PubMed ID: 8993358
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunization against Lyme disease--an important first step.
    Steigbigel RT; Benach JL
    N Engl J Med; 1998 Jul; 339(4):263-4. PubMed ID: 9673306
    [No Abstract]   [Full Text] [Related]  

  • 7. Lyme disease vaccine cleared for marketing.
    Miller JL
    Am J Health Syst Pharm; 1999 Feb; 56(3):206. PubMed ID: 10030501
    [No Abstract]   [Full Text] [Related]  

  • 8. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
    Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
    Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lyme borreliosis--vaccines in the "pipeline"].
    Kramer M
    MMW Fortschr Med; 1999 Jun; 141(25):52-3. PubMed ID: 10897909
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of Lyme disease after OspA vaccine.
    Schutzer SE; Luan J; Coyle PK
    N Engl J Med; 1997 Sep; 337(11):794-5. PubMed ID: 9289653
    [No Abstract]   [Full Text] [Related]  

  • 11. Lyme disease vaccine safe for all?
    Rahn DW
    Postgrad Med; 1999 Jun; 105(7):21. PubMed ID: 10376044
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.
    Stover CK; Bansal GP; Hanson MS; Burlein JE; Palaszynski SR; Young JF; Koenig S; Young DB; Sadziene A; Barbour AG
    J Exp Med; 1993 Jul; 178(1):197-209. PubMed ID: 8315378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter.
    Simon MM; Gern L; Hauser P; Zhong W; Nielsen PJ; Kramer MD; Brenner C; Wallich R
    Eur J Immunol; 1996 Dec; 26(12):2831-40. PubMed ID: 8977275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Availability of Lyme disease vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jan; 48(2):35-6, 43. PubMed ID: 9933128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective immunity elicited by rBCG vaccines.
    Stover CK; Bansal GP; Langerman S; Hanson MS
    Dev Biol Stand; 1994; 82():163-70. PubMed ID: 7958471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitopes on surface antigens other than OspA can elicit a bactericidal effect against Lyme disease borrelias.
    Shoberg RJ; Thomas DD
    J Infect Dis; 1995 Jan; 171(1):253-4. PubMed ID: 7528252
    [No Abstract]   [Full Text] [Related]  

  • 17. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi.
    Luke CJ; Carner K; Liang X; Barbour AG
    J Infect Dis; 1997 Jan; 175(1):91-7. PubMed ID: 8985201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against Lyme disease caused by diverse Borrelia burgdorferi.
    Fikrig E; Telford SR; Wallich R; Chen M; Lobet Y; Matuschka FR; Kimsey RB; Kantor FS; Barthold SW; Spielman A; Flavell RA
    J Exp Med; 1995 Jan; 181(1):215-21. PubMed ID: 7807004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with outer surface protein (Osp) A, but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi.
    Probert WS; Crawford M; Cadiz RB; LeFebvre RB
    J Infect Dis; 1997 Feb; 175(2):400-5. PubMed ID: 9203661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New vaccines for infectious diseases.
    Waterman S; Fritz C
    West J Med; 1998 Dec; 169(6):370-1. PubMed ID: 9866435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.